We are thrilled to announce that MoleculeSearch.ai has been featured on USPTO’s PatentsView! This recognition highlights our innovative use of chemical patent analysis in the field of drug discovery and beyond.

By searching for the SMILES strings of known HtrA1 inhibitors or other compounds mentioned in the patent, the researcher could identify other patents and molecules that share structural similarities.

MoleculeSearch.ai generates search results that include matching molecules, their associated patents, and information on the similarity between the query molecule and the matching molecules.

PharmaX, a fictional leading pharmaceutical company, was in the midst of an extensive research and development project for a new drug targeting a specific protein involved in cancer progression. The team was eager to ensure they were on the cutting edge of innovation, so they turned to moleculesearch.ai to identify valuable patents and gain insights that could fuel their research.

The field of cheminformatics plays a crucial role in drug discovery and development, where the ability to efficiently manage and analyze large amounts of chemical data is essential for identifying potential drug candidates and optimizing chemical reactions.

GPT models can be used in a variety of ways by industry professionals.

There are several analyses that we routinely carry out for clients using the USPTO patent data that is publicly available.

Pharmaceutical companies invest a significant amount of time and resources into developing new drugs and technologies that improve patient outcomes.

Here are the top 10 ways you can use SureChEMBL for patent analysis.

SureChEMBL is a dataset that is commonly used in cheminformatics and drug discovery research.

Patents play a significant role in the protection and commercialization of intellectual property.